Koyfin Home > Directory > Health Care > ANI Pharma Inc > Repurchase of Common Stock

ANI Pharma Inc Repurchase of Common Stock Chart (ANIP)

ANI Pharma Inc annual/quarterly Repurchase of Common Stock from 2013 to 2020.
  • ANI Pharma Inc Repurchase of Common Stock for the quarter ending June 06, 2020 was $-1m a 100.00% decrease of -1m year over year
  • ANI Pharma Inc Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-2m a 32.30% decrease of 0m year over year
  • ANI Pharma Inc Annual Repurchase of Common Stock for 2019 was $-1m a 36.08% decrease of 0m from 2018
  • ANI Pharma Inc Annual Repurchase of Common Stock for 2018 was $-1m a 60.70% decrease of 0m from 2017
  • ANI Pharma Inc Annual Repurchase of Common Stock for 2017 was $0m a -912.36% increase of 2m from 2016
Other Cash Flow Metrics:
  • ANI Pharma Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $8m a -89.99% decrease of -7m year over year
  • ANI Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $5m a 695.36% increase of 35m year over year
  • ANI Pharma Inc Total Revenue for the quarter ending December 12, 2018 was $57m a 18.63% increase of 11m year over year
View Chart On Koyfin

Quarterly ANIP Repurchase of Common Stock Data

06/2020$-1m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$-1m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual ANIP Repurchase of Common Stock Data

2019$-1m
2018$-1m
2017$0m
2016$-3m
2015$0m
2013$0m